A Simple Key For ABBV-744 BRD4 inhibition in cancer cell lines Unveiled
The current work examined the potential of utilizing ARV-825 and ABBV-744 to enhance the effectiveness of tamoxifen or fulvestrant moreover palbociclib. ARV-825 was effective in the two p53 wild-form (WT) breast tumor cells and in cells lacking useful p53 both by yourself or in combination with tamoxifen, while the effectiveness of ABBV-744 was lim